: A healthcare diagnostics company trading around $1.08 during its 2017–2021 watch period.
: A biopharmaceutical company focused on plasma-derived biologics, frequently cited as a high-ROI potential play among sub-$2 stocks. ⚠️ Key Risks of Sub-$2 Stocks
: The global private equity firm Warburg Pincus made a tender offer of $2.50 per share for a majority stake.